Author:
Hamberg Paul,de Jonge Maja J. A.,Seynaeve Caroline M.
Reference104 articles.
1. Aapro MS, Olsen SR, Alakl M, Murawsky M, Hurria A (2003) Safety profile of docetaxel in older patients with metastatic breast cancer. Breast Cancer Res Treat 82(1):532
2. Aapro MS, Köhne CH, Cohen HJ, Extermann M (2005) Never too old? Age should not be a barrier to enrolment in cancer clinical trials. Oncologist 10:198-204
3. Addeo R, Faiola V, Guarrasi R et al (2008) Liposomal pegylated doxorubicin plus vinorelbine combination as first-line chemotherapy for metastatic breast cancer in elderly women ≥65 years of age. Cancer Chemother Pharmacol 62:285-292
4. Anttila M, Laakso S, Nyländen P, Sotaniemi EA (1995) Pharmacokinetics of the novel antiestrogenic agent toremifene in subjects with altered liver and kidney function. Clin Pharmacol Ther 57:628-635
5. Bajetta E, Biganzoli L, Carnaghi C et al (1998) Oral doxifluridine plus levoleucovorin in elderly patients with advanced breast cancer. Cancer 83:1136-1141